buflomedil has been researched along with Recrudescence in 2 studies
buflomedil: RN given refers to parent cpd; synonym LL 1656 refers to HCl; structure
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Moriau, M | 1 |
Lavenne-Pardonge, E | 1 |
Crasborn, L | 1 |
von Frenckell, R | 1 |
Col-Debeys, C | 1 |
De Martiis, M | 1 |
Parenzi, A | 1 |
Barlattani, A | 1 |
De Martiis, A | 1 |
2 trials available for buflomedil and Recrudescence
Article | Year |
---|---|
The treatment of severe or recurrent deep venous thrombosis. Beneficial effect of the co-administration of antiplatelet agents with or without rheological effects, and anticoagulants.
Topics: Adult; Anticoagulants; Biomarkers; Blood Coagulation Tests; Blood Viscosity; Dipyridamole; Drug Ther | 1995 |
[Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
Topics: Aspirin; Clinical Trials as Topic; Dipyridamole; Humans; Ischemic Attack, Transient; Pyrrolidines; R | 1986 |